News about Drug Discovery & Development

Merck Shuts Down London Drug Discovery Centre, Moves R&D Focus to US

Merck has announced that it will discontinue its drug discovery operations in London, citing an increasingly challenging business environment in the UK. The company has abandoned plans to occupy the Belgrove House site at King’s Cross—which had been scheduled to open in 2027—and will relocate research activities primarily to existing sites in the USA.

Drug Discovery & Development | 12/09/2025 | By Darshana |  255

Alchemab Launches First-in-Human Trial of ATLX-1282, Secures 32 Million USD Financing Boost

Alchemab Therapeutics, a biopharmaceutical company that develops naturally occurring therapeutic antibodies from resilient individuals, has announced the initiation of its first-in-human phase 1 study of ATLX-1282.

Drug Discovery & Development | 10/09/2025 | By Darshana |  356

FDA tightens import controls on obesity drug ingredients amid safety concerns

The Food and Drug Administration (FDA) in the USA has intensified its scrutiny of imports containing GLP-1 drug ingredients, widely used in treatments for weight loss and diabetes, following increasing concerns over safety and quality.

Drug Discovery & Development | 06/09/2025 | By Darshana |  383

Roche Deploys Contivue Manufacturing Platform with CE Mark for nAMD Continuous Drug Delivery

Roche has received CE marking in the European Union for Contivue, its innovative Port Delivery Platform for administering Susvimo in the treatment of neovascular (wet) age-related macular degeneration (nAMD).

Drug Discovery & Development | 04/09/2025 | By Darshana |  299

Nanyang Biologics, NVIDIA, HPE and Equinix Collaborate to Build AI Drug Discovery Platform

Fischer Medical Ventures’ associate company, Nanyang Biologics (NYB), has entered into a strategic collaboration with global technology leaders NVIDIA, Hewlett Packard Enterprise (HPE), and Equinix to build VECURA – an AI-powered drug discovery platform.

Drug Discovery & Development | 03/09/2025 | By Dineshwori |  345

Piramal Pharma Solutions Supports George Medicines in Developing its New Drug for Hypertension, WIDAPLIK

Piramal Pharma Solutions leveraged its CDMO expertise to help George Medicines develop WIDAPLIK, the first and only FDA-approved triple combination therapy for hypertension, combining telmisartan, amlodipine, and indapamide to effectively lower blood pressure.

Drug Discovery & Development | 01/09/2025 | By Mrinmoy Dey |  218

US FDA Accepts Gadoquatrane for Review: Bayer

Bayer has submitted New Drug Application (NDA) for low dose contrast agent gadoquatrane to seek approval for contrast-enhanced Magnetic Resonance Imaging (MRI) of the Central Nervous System (CNS) and other body regions for adults and paediatric patients including neonates.

Drug Discovery & Development | 27/08/2025 | By Dineshwori |  198

Gland Pharma Secures USFDA Approval for Ready-to-Use Vasopressin Injection

The product is bioequivalent and therapeutically equivalent to the reference drug Vasostrict. Vasopressin is indicated for adults with vasodilatory shock who remain hypotensive despite adequate fluid resuscitation and catecholamine support.

Drug Discovery & Development | 27/08/2025 | By Darshana |  180

Abbott Introduces FreeStyle Libre 2 Plus: Continuous Glucose Monitoring Without Fingersticks

Abbott, a global healthcare leader, has launched the FreeStyle Libre 2 Plus sensor in India, a device that delivers automatic glucose readings every minute directly to a user’s smartphone. The innovation aims to provide people living with diabetes greater confidence, precision, and ease in managing their condition.

Drug Discovery & Development | 22/08/2025 | By Darshana |  355

Stealth BioTherapeutics' Elamipretide NDA Resubmission Accepted for Review by US FDA

Stealth BioTherapeutics has announced that the US FDA has accepted for review its resubmitted New Drug Application for elamipretide to treat Barth syndrome, with a planned goal date of September 26, 2025.

Drug Discovery & Development | 22/08/2025 | By Mrinmoy Dey |  234